ILMN Quote, Financials, Valuation and Earnings

Delcath Systems has a net margin of 12.58% compared to Illumina's net margin of 5.4%. Illumina's return on equity of -34.38% beat Delcath Systems's return on equity of -40.28%.

Illumina has a consensus price target of $106.53, signalling upside risk potential of 28.1%. On the other hand Delcath Systems has an analysts' consensus of $24.08 which suggests that it could grow by 47%. Given that Delcath Systems has higher upside potential than Illumina, analysts believe Delcath Systems is more attractive than Illumina.

Illumina has a beta of 1.324, which suggesting that the stock is 32.43% more volatile than S&P 500. In comparison Delcath Systems has a beta of 0.948, suggesting its less volatile than the S&P 500 by 5.238%.

Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina pays -- of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend.

Illumina quarterly revenues are $1B, which are larger than Delcath Systems quarterly revenues of $19.8M. Illumina's net income of $131M is higher than Delcath Systems's net income of $1.1M. Notably, Illumina's price-to-earnings ratio is -- while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 3.05x versus 10.06x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

Danaher has a net margin of 12.58% compared to Illumina's net margin of 16.62%. Illumina's return on equity of -34.38% beat Danaher's return on equity of 7.38%.

Illumina has a consensus price target of $106.53, signalling upside risk potential of 28.1%. On the other hand Danaher has an analysts' consensus of $247.35 which suggests that it could grow by 28.11%. Given that Danaher has higher upside potential than Illumina, analysts believe Danaher is more attractive than Illumina.

Illumina has a beta of 1.324, which suggesting that the stock is 32.43% more volatile than S&P 500. In comparison Danaher has a beta of 0.772, suggesting its less volatile than the S&P 500 by 22.765%.

Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Danaher offers a yield of 0.59% to investors and pays a quarterly dividend of $0.32 per share. Illumina pays -- of its earnings as a dividend. Danaher pays out 19.7% of its earnings as a dividend. Danaher's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Illumina quarterly revenues are $1B, which are smaller than Danaher quarterly revenues of $5.7B. Illumina's net income of $131M is lower than Danaher's net income of $954M. Notably, Illumina's price-to-earnings ratio is -- while Danaher's PE ratio is 37.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 3.05x versus 5.92x for Danaher. Usually stocks with elevated PS ratios are considered overvalued.

Exact Sciences has a net margin of 12.58% compared to Illumina's net margin of -14.32%. Illumina's return on equity of -34.38% beat Exact Sciences's return on equity of -35.57%.

Illumina has a consensus price target of $106.53, signalling upside risk potential of 28.1%. On the other hand Exact Sciences has an analysts' consensus of $68.87 which suggests that it could grow by 24.82%. Given that Illumina has higher upside potential than Exact Sciences, analysts believe Illumina is more attractive than Exact Sciences.

Illumina has a beta of 1.324, which suggesting that the stock is 32.43% more volatile than S&P 500. In comparison Exact Sciences has a beta of 0.977, suggesting its less volatile than the S&P 500 by 2.282%.

Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina pays -- of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend.

Illumina quarterly revenues are $1B, which are larger than Exact Sciences quarterly revenues of $706.8M. Illumina's net income of $131M is higher than Exact Sciences's net income of -$101.2M. Notably, Illumina's price-to-earnings ratio is -- while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 3.05x versus 3.62x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

Star Equity Holdings has a net margin of 12.58% compared to Illumina's net margin of -9.1%. Illumina's return on equity of -34.38% beat Star Equity Holdings's return on equity of -15.99%.

Illumina has a consensus price target of $106.53, signalling upside risk potential of 28.1%. On the other hand Star Equity Holdings has an analysts' consensus of $8.50 which suggests that it could grow by 286.36%. Given that Star Equity Holdings has higher upside potential than Illumina, analysts believe Star Equity Holdings is more attractive than Illumina.

Illumina has a beta of 1.324, which suggesting that the stock is 32.43% more volatile than S&P 500. In comparison Star Equity Holdings has a beta of 1.002, suggesting its more volatile than the S&P 500 by 0.203%.

Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Equity Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina pays -- of its earnings as a dividend. Star Equity Holdings pays out -19.54% of its earnings as a dividend.

Illumina quarterly revenues are $1B, which are larger than Star Equity Holdings quarterly revenues of $12.9M. Illumina's net income of $131M is higher than Star Equity Holdings's net income of -$1.2M. Notably, Illumina's price-to-earnings ratio is -- while Star Equity Holdings's PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 3.05x versus 0.12x for Star Equity Holdings. Usually stocks with elevated PS ratios are considered overvalued.